Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial
Titel:
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial
Auteur:
Soo, Ross A. Huat Tan, Eng Hayashi, Hidetoshi Seto, Takashi Lin, Chia-Chi Ou, Sai-Hong Ignatius Kim, Dong-Wan Liu, Geoffrey Abbattista, Antonello Martini, Jean-François Hooi Wong, Chew Toffalorio, Francesca Solomon, Benjamin J.